{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:37:23Z","timestamp":1790620643286,"version":"4.1.0"},"reference-count":70,"publisher":"IMR Press","issue":"5","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmazie"],"abstract":"<jats:p>Ferroptosis is a regulated form of cell death characterized by iron-dependent lipid peroxidation. Intracellular iron promotes the generation of reactive oxygen species via the Fenton reaction, leading to lipid peroxide accumulation, membrane damage, and subsequent cell death. Increasing evidence indicates that ferroptosis plays a critical role in cancer progression and therapeutic response. Recent studies have identified a diverse range of ferroptosis-inducing compounds, including natural products, semi-synthetic derivatives, and synthetic small molecules, which exert antitumor effects by targeting key regulatory nodes such as iron metabolism, system Xc-, and glutathione peroxidase 4. However, the clinical translation of ferroptosis-based strategies remains limited by insufficient tumor selectivity, systemic toxicity, the lack of reliable biomarkers, and adaptive resistance mechanisms. In this review, we summarize the molecular regulatory networks governing ferroptosis, critically evaluate representative ferroptosis-inducing compounds and the associated mechanisms of action, and discuss current translational challenges and unresolved controversies. Furthermore, an integrative framework is proposed to define ferroptosis as a context-dependent metabolic vulnerability in tumors, thereby providing a conceptual basis for the rational development of ferroptosis-based anticancer therapies.<\/jats:p>","DOI":"10.31083\/pharmazie51559","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T08:35:36Z","timestamp":1780130136000},"source":"Crossref","is-referenced-by-count":1,"title":["Research Progress on Ferroptosis-Inducing Compounds in Tumor Cells"],"prefix":"10.31083","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0396-0789","authenticated-orcid":true,"given":"Ruiyuan","family":"Zhang","sequence":"first","affiliation":[{"name":"School of Basic Medical Sciences, Jiamusi University, 154007 Jiamusi, Heilongjiang, China"},{"name":"Department of Basic Medicine, School of Medicine, Taizhou University, 318000 Taizhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4845-8744","authenticated-orcid":true,"given":"Meiyun","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Basic Medicine, School of Medicine, Taizhou University, 318000 Taizhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9017-7377","authenticated-orcid":true,"given":"Mansa","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Basic Medicine, School of Medicine, Taizhou University, 318000 Taizhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4360-3620","authenticated-orcid":true,"given":"Manyu","family":"Xu","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Jiamusi University, 154007 Jiamusi, Heilongjiang, China"},{"name":"Department of Basic Medicine, School of Medicine, Taizhou University, 318000 Taizhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3682-2676","authenticated-orcid":true,"given":"Xi","family":"Han","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Jiamusi University, 154007 Jiamusi, Heilongjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6897-6216","authenticated-orcid":true,"given":"Qiongying","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Basic Medicine, School of Medicine, Taizhou University, 318000 Taizhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012; 149: 1060\u20131072.","DOI":"10.1016\/j.cell.2012.03.042"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nature Reviews Molecular Cell Biology. 2021; 22: 266\u2013282.","DOI":"10.1038\/s41580-020-00324-8"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Stockwell BR. Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications. Cell. 2022; 185: 2401\u20132421.","DOI":"10.1016\/j.cell.2022.06.003"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nature Reviews Cancer. 2022; 22: 381\u2013396.","DOI":"10.1038\/s41568-022-00459-0"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Research. 2020; 31: 107\u2013125.","DOI":"10.1038\/s41422-020-00441-1"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Badgley MA, Kremer DM, Maurer HC, DelGiorno KE, Lee HJ, Purohit V, et al. Cysteine depletion induces pancreatic tumor ferroptosis in mice. Science (New York, N.Y.). 2020; 368: 85\u201389.","DOI":"10.1126\/science.aaw9872"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Chen X, Comish PB, Tang D, Kang R. Characteristics and biomarkers of ferroptosis. Frontiers in Cell and Developmental Biology. 2021; 9: 637162.","DOI":"10.3389\/fcell.2021.637162"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Liang C, Zhang X, Yang M, Dong X. Recent Progress in Ferroptosis Inducers for Cancer Therapy. Advanced Materials (Deerfield Beach, Fla.). 2019; 31: e1904197.","DOI":"10.1002\/adma.201904197"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Hu Y, Guo N, Yang T, Yan J, Wang W, Li X. The Potential Mechanisms by which Artemisinin and Its Derivatives Induce Ferroptosis in the Treatment of Cancer. Oxidative Medicine and Cellular Longevity. 2022; 2022: 1458143.","DOI":"10.1155\/2022\/1458143"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Stockwell BR, Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. cell. 2017; 171: 273\u2013285.","DOI":"10.1016\/j.cell.2017.09.021"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao N, et al. Ferroptosis: past, present and future. Cell Death & Disease. 2020; 11: 88.","DOI":"10.1038\/s41419-020-2298-2"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015; 520: 57\u201362.","DOI":"10.1038\/nature14344"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Hassannia B, Vandenabeele P, Vanden Berghe T. Targeting Ferroptosis to Iron Out Cancer. Cancer Cell. 2019; 35: 830\u2013849.","DOI":"10.1016\/j.ccell.2019.04.002"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Chen X, Kang R, Kroemer G, Tang D. Broadening horizons: the role of ferroptosis in cancer. Nature Reviews Clinical Oncology. 2021; 18: 280\u2013296.","DOI":"10.1038\/s41571-020-00462-0"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Masaldan S, Bush AI, Devos D, Rolland AS, Moreau C. Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration. Free Radical Biology and Medicine. 2019; 133: 221\u2013233.","DOI":"10.1016\/j.freeradbiomed.2018.09.033"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Chen L, Hambright WS, Na R, Ran Q. Ablation of the ferroptosis inhibitor glutathione peroxidase 4 in neurons results in rapid motor neuron degeneration and paralysis. Journal of Biological Chemistry. 2015; 290: 28097\u201328106.","DOI":"10.1074\/jbc.M115.680090"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Fang X, Wang H, Han D, Xie E, Yang X, Wei J, et al. Ferroptosis as a target for protection against cardiomyopathy. Proceedings of the National Academy of Sciences of the United States of America. 2019; 116: 2672\u20132680.","DOI":"10.1073\/pnas.1821022116"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Sanz AB, Sanchez-Ni\u00f1o MD, Ramos AM, Ortiz A. Regulated cell death pathways in kidney disease. Nature Reviews. Nephrology. 2023; 19: 281\u2013299.","DOI":"10.1038\/s41581-023-00694-0"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Zhang Y, Xin L, Xiang M, Shang C, Wang Y, Wang Y, et al. The molecular mechanisms of ferroptosis and its role in cardiovascular disease. Biomedicine & Pharmacotherapy. 2022; 145: 112423.","DOI":"10.1016\/j.biopha.2021.112423"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Friedmann Angeli JP, Schneider M, Proneth B, Tyurina YY, Tyurin VA, Hammond VJ, et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nature Cell Biology. 2014; 16: 1180\u20131191.","DOI":"10.1038\/ncb3064"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Wu J, Wang Y, Jiang R, Xue R, Yin X, Wu M, et al. Ferroptosis in liver disease: new insights into disease mechanisms. Cell Death Discovery. 2021; 7: 276.","DOI":"10.1038\/s41420-021-00660-4"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Doll S, Proneth B, Tyurina YY, Panzilius E, Kobayashi S, Ingold I, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nature Chemical Biology. 2017; 13: 91\u201398.","DOI":"10.1038\/nchembio.2239"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019; 575: 688\u2013692.","DOI":"10.1038\/s41586-019-1705-2"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Chen F, Kang R, Tang D, Liu J. Ferroptosis: principles and significance in health and disease. Journal of Hematology & Oncology. 2024; 17: 41.","DOI":"10.1186\/s13045-024-01564-3"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Tong X, Tang R, Xiao M, Xu J, Wang W, Zhang B, et al. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research. Journal of Hematology & Oncology. 2022; 15: 174.","DOI":"10.1186\/s13045-022-01392-3"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Sun K, Li C, Liao S, Yao X, Ouyang Y, Liu Y, et al. Ferritinophagy, a form of autophagic ferroptosis: New insights into cancer treatment. Frontiers in Pharmacology. 2022; 13: 1043344.","DOI":"10.3389\/fphar.2022.1043344"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Li S, Huang P, Lai F, Zhang T, Guan J, Wan H, et al. Mechanisms of Ferritinophagy and Ferroptosis in Diseases. Molecular Neurobiology. 2024; 61: 1605\u20131626.","DOI":"10.1007\/s12035-023-03640-0"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Jin Y, Chen L, Li L, Huang G, Huang H, Tang C. SNAI2 promotes the development of ovarian cancer through regulating ferroptosis. Bioengineered. 2022; 13: 6451\u20136463.","DOI":"10.1080\/21655979.2021.2024319"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Zeng J, Zhang X, Lin Z, Zhang Y, Yang J, Dou P, et al. Harnessing ferroptosis for enhanced sarcoma treatment: mechanisms, progress and prospects. Experimental Hematology & Oncology. 2024; 13: 31.","DOI":"10.1186\/s40164-024-00498-3"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Dixon SJ, Olzmann JA. The cell biology of ferroptosis. Nature Reviews Molecular Cell Biology. 2024; 25: 424\u2013442.","DOI":"10.1038\/s41580-024-00703-5"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Bay\u0131r H, Dixon SJ, Tyurina YY, Kellum JA, Kagan VE. Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney. Nature Reviews. Nephrology. 2023; 19: 315\u2013336.","DOI":"10.1038\/s41581-023-00689-x"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Lv Y, Wu M, Wang Z, Wang J. Ferroptosis: From regulation of lipid peroxidation to the treatment of diseases. Cell Biology and Toxicology. 2023; 39: 827\u2013851.","DOI":"10.1007\/s10565-022-09778-2"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Li X, Meng F, Wang H, Sun L, Chang S, Li G, et al. Iron accumulation and lipid peroxidation: implication of ferroptosis in hepatocellular carcinoma. Frontiers in Endocrinology. 2023; 14: 1319969.","DOI":"10.3389\/fendo.2023.1319969"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Wang J, Wu N, Peng M, Oyang L, Jiang X, Peng Q, et al. Ferritinophagy: research advance and clinical significance in cancers. Cell Death Discovery. 2023; 9: 463.","DOI":"10.1038\/s41420-023-01753-y"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Ning J, Wen L, Qiao L. Ferritinophagy: molecular mechanisms and its crosstalk with ferroptosis in chronic respiratory diseases. Cell Biology and Toxicology. 2026; 42: 31.","DOI":"10.1007\/s10565-026-10150-x"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Rochette L, Dogon G, Rigal E, Zeller M, Cottin Y, Vergely C. Lipid Peroxidation and Iron Metabolism: Two Corner Stones in the Homeostasis Control of Ferroptosis. International Journal of Molecular Sciences. 2022; 24: 449.","DOI":"10.3390\/ijms24010449"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Ursini F, Maiorino M. Lipid peroxidation and ferroptosis: The role of GSH and GPx4. Free Radical Biology & Medicine. 2020; 152: 175\u2013185.","DOI":"10.1016\/j.freeradbiomed.2020.02.027"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Kraft VA, Bezjian CT, Pfeiffer S, Ringelstetter L, Mu\u0308ller C, Zandkarimi F, et al. GTP cyclohydrolase 1\/tetrahydrobiopterin counteract ferroptosis through lipid remodeling. ACS Central Science. 2019; 6: 41\u201353.","DOI":"10.1021\/acscentsci.9b01063"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Mao C, Liu X, Zhang Y, Lei G, Yan Y, Lee H, et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature. 2021; 593: 586\u2013590.","DOI":"10.1038\/s41586-021-03539-7"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Dodson M, Castro-Portuguez R, Zhang DD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biology. 2019; 23: 101107.","DOI":"10.1016\/j.redox.2019.101107"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Kerins MJ, Ooi A. The Roles of NRF2 in Modulating Cellular Iron Homeostasis. Antioxidants & Redox Signaling. 2018; 29: 1756\u20131773.","DOI":"10.1089\/ars.2017.7176"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Wu J, Minikes AM, Gao M, Bian H, Li Y, Stockwell BR, et al. Intercellular interaction dictates cancer cell ferroptosis via NF2\u2013YAP signalling. Nature. 2019; 572: 402\u2013406.","DOI":"10.1038\/s41586-019-1426-6"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Lee H, Zandkarimi F, Zhang Y, Meena JK, Kim J, Zhuang L, et al. Energy-stress-mediated AMPK activation inhibits ferroptosis. Nature Cell Biology. 2020; 22: 225\u2013234.","DOI":"10.1038\/s41556-020-0461-8"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Yang WS, Stockwell BR. Ferroptosis: Death by Lipid Peroxidation. Trends in Cell Biology. 2016; 26: 165\u2013176.","DOI":"10.1016\/j.tcb.2015.10.014"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Kagan VE, Mao G, Qu F, Angeli JPF, Doll S, Croix CS, et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nature Chemical Biology. 2017; 13: 81\u201390.","DOI":"10.1038\/nchembio.2238"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Zhang Y, Shi J, Liu X, Feng L, Gong Z, Koppula P, et al. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nature Cell Biology. 2018; 20: 1181\u20131192.","DOI":"10.1038\/s41556-018-0178-0"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Tang D, Kroemer G. Ferroptosis. Current Biology. 2020; 30: R1292\u2013R1297.","DOI":"10.1016\/j.cub.2020.09.068"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Zhang Y, Swanda RV, Nie L, Liu X, Wang C, Lee H, et al. mTORC1 couples cyst (e) ine availability with GPX4 protein synthesis and ferroptosis regulation. Nature Communications. 2021; 12: 1589.","DOI":"10.1038\/s41467-021-21841-w"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Xu T, Ding W, Ji X, Ao X, Liu Y, Yu W, et al. Molecular mechanisms of ferroptosis and its role in cancer therapy. Journal of Cellular and Molecular Medicine. 2019; 23: 4900\u20134912.","DOI":"10.1111\/jcmm.14511"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Doll S, Freitas FP, Shah R, Aldrovandi M, da Silva MC, Ingold I, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019; 575: 693\u2013698.","DOI":"10.1038\/s41586-019-1707-0"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Lei G, Mao C, Yan Y, Zhuang L, Gan B. Ferroptosis, radiotherapy, and combination therapeutic strategies. Protein & Cell. 2021; 12: 836\u2013857.","DOI":"10.1007\/s13238-021-00841-y"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Kim SA, Kang OH, Kwon DY. Cryptotanshinone induces cell cycle arrest and apoptosis of NSCLC cells through the PI3K\/Akt\/GSK-3\u03b2 pathway. International Journal of Molecular Sciences. 2018; 19: 2739.","DOI":"10.3390\/ijms19092739"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Chen GQ, Benthani FA, Wu J, Liang D, Bian ZX, Jiang X. Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis. Cell Death and Differentiation. 2020; 27: 242\u2013254.","DOI":"10.1038\/s41418-019-0352-3"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Song J, He GN, Dai L. A comprehensive review on celastrol, triptolide and triptonide: Insights on their pharmacological activity, toxicity, combination therapy, new dosage form and novel drug delivery routes. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 2023; 162: 114705.","DOI":"10.1016\/j.biopha.2023.114705"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Feng M, Wu H, Zhu L, Gao J, Deng G. Triptolide Promotes Ferroptosis in Cervical Cancer Cell via NRF2\/xCT\/GPX4. Phytotherapy Research: PTR. 2025; 39: 875\u2013887.","DOI":"10.1002\/ptr.8398"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Wei R, Zhao Y, Wang J, Yang X, Li S, Wang Y, et al. Tagitinin C induces ferroptosis through PERK-Nrf2-HO-1 signaling pathway in colorectal cancer cells. International Journal of Biological Sciences. 2021; 17: 2703\u20132717.","DOI":"10.7150\/ijbs.59404"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Dolma S, Lessnick SL, Hahn WC, Stockwell BR. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell. 2003; 3: 285\u2013296.","DOI":"10.1016\/S1535-6108(03)00050-3"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"Dixon SJ, Patel DN, Welsch M, Skouta R, Lee ED, Hayano M, et al. Pharmacological inhibition of cystine\u2013glutamate exchange induces endoplasmic reticulum stress and ferroptosis. eLife. 2014; 3: e02523.","DOI":"10.7554\/eLife.02523"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"Zhao Y, Li Y, Zhang R, Wang F, Wang T, Jiao Y. The Role of Erastin in Ferroptosis and Its Prospects in Cancer Therapy. OncoTargets and Therapy. 2020; 13: 5429\u20135441.","DOI":"10.2147\/OTT.S254995"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"Yin LB, Li ZW, Wang JL, Wang L, Hou L, Hu SY, et al. Sulfasalazine inhibits esophageal cancer cell proliferation by mediating ferroptosis. Chemical Biology & Drug Design. 2023; 102: 730\u2013737.","DOI":"10.1111\/cbdd.14281"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"Zhao C, Yu Y, Yin G, Xu C, Wang J, Wang L, et al. Sulfasalazine promotes ferroptosis through AKT-ERK1\/2 and P53-SLC7A11 in rheumatoid arthritis. Inflammopharmacology. 2024; 32: 1277\u20131294.","DOI":"10.1007\/s10787-024-01439-6"},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"Yuan S, Wei C, Liu G, Zhang L, Li J, Li L, et al. Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF\u20101\u03b1\/SLC7A11 pathway. Cell Proliferation. 2022; 55: e13158.","DOI":"10.1111\/cpr.13158"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"Xu X, Li Y, Wu Y, Wang M, Lu Y, Fang Z, et al. Increased ATF2 expression predicts poor prognosis and inhibits sorafenib-induced ferroptosis in gastric cancer. Redox Biology. 2023; 59: 102564.","DOI":"10.1016\/j.redox.2022.102564"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"Sun S, Shen J, Jiang J, Wang F, Min J. Targeting ferroptosis opens new avenues for the development of novel therapeutics. Signal Transduction and Targeted Therapy. 2023; 8: 372.","DOI":"10.1038\/s41392-023-01606-1"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"Li S, He Y, Chen K, Sun J, Zhang L, He Y, et al. RSL3 drives ferroptosis through NF\u2010\u03baB pathway activation and GPX4 depletion in glioblastoma. Oxidative Medicine and Cellular Longevity. 2021; 2021: 2915019.","DOI":"10.1155\/2021\/2915019"},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"Yang J, Mo J, Dai J, Ye C, Cen W, Zheng X, et al. Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2\/HO-1 signalling pathway in KRAS mutant colorectal cancer. Cell Death & Disease. 2021; 12: 1079.","DOI":"10.1038\/s41419-021-04367-3"},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"Shimada K, Skouta R, Kaplan A, Yang WS, Hayano M, Dixon SJ, et al. Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis. Nature Chemical Biology. 2016; 12: 497\u2013503.","DOI":"10.1038\/nchembio.2079"},{"key":"ref68","doi-asserted-by":"publisher","unstructured":"Sun Y, Berleth N, Wu W, Schl\u00fctermann D, Deitersen J, Stuhldreier F, et al. Fin56-induced ferroptosis is supported by autophagy-mediated GPX4 degradation and functions synergistically with mTOR inhibition to kill bladder cancer cells. Cell Death & Disease. 2021; 12: 1028.","DOI":"10.1038\/s41419-021-04306-2"},{"key":"ref69","doi-asserted-by":"publisher","unstructured":"Wei X, Huang Q, Huang J, Yu L, Chen J. Erastin induces ferroptosis in cervical cancer cells via Nrf2\/HO-1 signaling pathway. International Journal of Immunopathology and Pharmacology. 2023; 37: 3946320231219348.","DOI":"10.1177\/03946320231219348"},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"Li J, Liu J, Xu Y, Wu R, Chen X, Song X, et al. Tumor heterogeneity in autophagy-dependent ferroptosis. Autophagy. 2021; 17: 3361\u20133374.","DOI":"10.1080\/15548627.2021.1872241"}],"container-title":["Die Pharmazie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/Pharmazie\/81\/5\/10.31083\/Pharmazie51559","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T08:35:38Z","timestamp":1780130138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/Pharmazie\/81\/5\/10.31083\/Pharmazie51559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":70,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"alternative-id":["S0031-7144(26)02906-0"],"URL":"https:\/\/doi.org\/10.31083\/pharmazie51559","relation":{},"ISSN":["0031-7144","3053-691X"],"issn-type":[{"value":"0031-7144","type":"print"},{"value":"3053-691X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"article-number":"51559"}}